145 results on '"Mirshahi, Faridoddin"'
Search Results
2. Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis
3. A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis
4. Loss of TIM4-Dependent Efferocytosis in Kupffer Cells Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
5. Decoding hepatocyte transcriptional responses in murine non-alcoholic steatohepatitis using single-nucleus RNA-sequencing
6. A shift in the hepatic immunological pattern from predominant adaptive immunity to innate immunity compromises tissue-specific immunity and leads to HCC
7. Restoration of CD4 +T helper cells without modulating the hepatic inflammatory pattern is not sufficient to prevent HCC
8. The multifaceted role of natriuretic peptides in metabolic syndrome
9. Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
10. Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease
11. Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease
12. Restoration of CD4+ T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC
13. sj-docx-1-pat-10.1177_2632010X231162317 – Supplemental material for Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease
14. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
15. An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis
16. The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
17. Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
18. Development of Alcohol‐Associated Hepatitis Is Associated With Specific Changes in Gut‐Modified Bile Acids
19. Withaferin A Acts as a Novel Ligand and Regulator of Liver X Receptor-α in Hepatocellular Carcinoma
20. Restoration of CD4 + T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC.
21. Identification of a metabolic, transcriptomic and molecular signature of PNPLA3-mediated acceleration of steatohepatitis
22. Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis
23. WED-422 - Decoding hepatocyte transcriptional responses in murine non-alcoholic steatohepatitis using single-nucleus RNA-sequencing
24. Withaferin A Acts as a Novel Regulator of Liver X Receptor-α in HCC
25. Distinct Hepatic Immunological Patterns are Associated With the Progression or Inhibition of Hepatocellular Carcinoma
26. Emerging roles of AATF: Checkpoint signaling and beyond
27. The development and severity of alcoholic hepatitis is associated with decreased intestinal microbiome-derived secondary bile acid isoursodeoxycholic acid
28. Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development
29. Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity
30. Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancer
31. Emerging roles of AATF: Checkpoint signaling and beyond.
32. 318 – Haptoglobin 2 Allele is Associated with Increased Risk and Severity of Alcoholic Hepatitis
33. THU-295-Non-alcoholic fatty liver disease is associated with QTc lengthening in the general population
34. A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
35. Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancer.
36. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
37. Dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis
38. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
39. Suppression of IGF binding protein‐3 by palmitate promotes hepatic inflammatory responses
40. Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein
41. Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese
42. Sa1672 Manassatin, a Plant Based Compound Ameliorates AMPK and Suppresses ERK1/2 Pathways in Human Hepatocytes - A Novel Therapeutic Target for Nonalcoholic Fatty Liver Disease
43. Mo1544 Nonalcoholic Steatohepatitis Is Associated With a State of Betaine-Insufficiency
44. Sa1652 Mechanistic and Therapeutic Implications of Distinct Pro-and Anti-inflammatory Circulating Eicosanoids in Patients With Severe Alcoholic Hepatitis
45. Sa1663 Dual Photon Microscopy-Based Quantitation of Fibrosis-Related Collagen Properties (qFPs) to Model Disease Progression in Steatohepatitis
46. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis
47. The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis.
48. Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease
49. Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease
50. Su1804 Macrophage Phenotypes in Humans With NAFLD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.